Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tiagabine for Cocaine Dependence
NCT00086255Phase 2Completed
- Sponsor
- National Institute on Drug Abuse
- Start
- Oct 2002
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in cocaine dependence comparing Tiagabine with Placebo (2 arms). Primary endpoints: Days of cocaine use at 12 weeks, Urine benzoylecgonine (BE) results at 12 weeks and 2 more. Started Oct 2002; status: completed.
02
Drugs
tiagabine
03
Conditions
cocaine dependence
Beyond the preview
Go deeper on NCT00086255.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00086255.